Harris Kaplan Featured on Russo Edge Podcast: Why Approval Isn't the Finish Line

Harris Kaplan, Managing Partner of Litmys and author of Approval Is Not Adoption, joined host Solomon Wilcots on the Russo Edge podcast for a discussion about why regulatory approval alone does not guarantee commercial success in the life sciences industry.

Drawing on more than four decades of commercialization experience, Harris explores the factors that influence whether physicians prescribe, payers provide access to, and patients ultimately adopt new therapies. The conversation examines why commercial considerations must be addressed earlier in development, when companies still have opportunities to shape clinical evidence, product differentiation, and market positioning.

Harris also discusses his recently released book, Approval Is Not Adoption, and Litmys' RAMPx™ model, which evaluates product advantage, ease of adoption, and willingness to adopt to help companies better understand real-world market potential before launch.

Listen to or watch the full episode: Russo Partners | YouTube | Spotify | Apple Podcasts